Top Markets
#1 Siren Siren +34.29%
#2 Wiki Cat Wiki Cat +29.28%
#3 Bitway Bitway +20.25%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.79%
#5 TRIA TRIA +17.08%
#6 PulseChain PulseChain +16.92%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.84%
#8 Velvet Velvet +15.27%
#9 Cysic Cysic +14.22%
#10 The Grays Currency The Grays Currency +14.20%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Rangering i aksjer #30681
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Aksjekurs
$0.91968646
Markedsverdi
$15.91M
Endring (1 dag)
2.23%
Endring (1 år)
-54.41%
Land
KR
Handel Xcell Therapeutics, Inc. (373110)

Kategori

Healthcare
Aksjeprishistorikk for Xcell Therapeutics, Inc. (373110)
Høyeste sluttskurs: $0.93 den 2026-08-01

Laveste sluttskurs: $5.30 den 2024-07-01
Aksjeprishistorikk for Xcell Therapeutics, Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 5.84%
2025 -59.67%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 50.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.87%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 13.01%
BE